Healthcare - Biotechnology - NASDAQ - US
$ 3.125
-8.89 %
$ 201 M
Market Cap
-2.02
P/E
Price Target
Average
369.33%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
35.34%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Inozyme Pharma, Inc.
Wall Street analysts predict an average 1-year price target for INZY of $14.7 , with forecasts ranging from a low of $14 to a high of $16 .
INZY Lowest Price Target
Wall Street Target
14 USD
348.00%
INZY Average Price Target
Wall Street Target
14.7 USD
369.33%
INZY Highest Price Target
Wall Street Target
16 USD
412.00%
REVENUE FORECAST
Revenue Forecast Chart INZY
EBIT FORECAST
EBIT Forecast Chart INZY
NET INCOME FORECAST
Net Income Chart INZY